Skip to content

The Impact of Preoperative Anxiety State on Propofol-Related Euphoria in Patients After Painless Gastroscopy

The Impact of Preoperative Anxiety State on Propofol-Related Euphoria in Patients After Painless Gastroscopy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114870
Enrollment
Unknown
Registered
2025-12-18
Start date
2025-12-20
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mood changes

Interventions

Anxious individuals group:None
Healthy individuals group:None

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Scheduled to undergo painless gastroscopy with simple endoscopic procedures, such as clipping of single small polyps, HP testing, etc. 2. No gender limitation. 3. Aged between 18 and 65 years old (inclusive). 4. Body mass index (BMI) ranging from 18 kg/m² to 30 kg/m² (exclusive). 5. American Society of Anesthesiologists (ASA) physical status classification: Class I–II. 6. Normal liver and kidney functions. 7. Provide informed consent, voluntarily participate in the trial, and sign the informed consent form by the subjects themselves

Exclusion criteria

Exclusion criteria: 1. Requiring endoscopic diagnosis and treatment technologies with complex procedures or strong noxious stimulation, such as removal of upper gastrointestinal foreign bodies, esophageal stricture dilation, etc. 2. Having severe cardio-cerebrovascular diseases, stroke, diabetes mellitus, etc. 3. Being identified as having difficult airway management. 4. Having hepatic or renal insufficiency. 5. Having a history of other mental or neurological diseases (e.g., schizophrenia, mania, bipolar disorder, confusion, epilepsy, neuralgia, etc.), a history of taking corresponding medications for mental or neurological diseases (e.g., antidepressants, anxiolytics, anticonvulsants, antiepileptics, etc.), or having cognitive impairment. 6. Having allergies or contraindications to the study drugs. 7. Having speech or cognitive dysfunction. 8. Having active infection (defined as white blood cell count > 10×10?/L or body temperature > 38?). 9. Having a history of chronic alcoholism. 11. Being pregnant women. 12. Having participated in other clinical trials of drugs or medical devices within 3 months prior to the screening period. 13. Refusing to participate in this study. 14. Being deemed ineligible by the investigators.

Design outcomes

Primary

MeasureTime frame
Incidence of euphoria;Postoperative emotional outcome;

Secondary

MeasureTime frame
Risk of euphoria addiction;Degree and duration of euphoria;Fatigue condition;Short-term sleep in the 72h postoperative period;Perioperative adverse events;Changes in postoperative anxiety level;Subjects' dreaming;Subjects' satisfaction with the quality of anesthesia;Pain level;

Countries

China

Contacts

Public ContactJu Gao

Northern Jiangsu People's Hospital Anesthesiology Department

doctor2227@163.com+86 180 5106 3988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026